China successfully developed a new vaccine against H5N1 for humans

According to the Xinhua News Agency, on January 6, an official from China's Center for Disease Control and Prevention (CDC) said it had developed a new recombinant vaccine to prevent H5N1 virus and researchers. as well as pharmaceutical companies that can develop or produce to use this vaccine for humans.

The official also said the new vaccine was prepared by Chinese and American CDCs based on studies of H5N1 infections in southern China.

(Photo: cache.el-mundo.net) According to the official, the researchers found that the virus samples collected from H5N1 cases in South China were completely different from antigens compared to viruses. was previously selected for vaccine preparation. He said that this is the first time China has developed a new vaccine against H5N1 for humans, a major contribution to the prevention of this deadly disease.

The World Health Organization (WHO) has also announced the new vaccine on its website and said "research institutes, companies and others are interested in developing a vaccine to prevent disease." "This new vaccine can be used.

Also on January 6, the Hong Kong Administration said test results from wild birds here confirmed the existence of the H5N1 deadly strain.

A report by the Hong Kong Department of Agriculture, Fisheries and Conservation said tests were carried out on bird carcasses collected in the shopping and residential areas of Causeway County during the last days of the year.

In 1997, in its first appearance in Hong Kong, the H5N1 virus claimed the lives of six people and caused the regional government to destroy all herds of about 1.5 million birds.